Literature DB >> 5154887

Chronic proliferative arthritis of mice induced by Mycoplasma arthritidis. I. Induction of disease and histopathological characteristics.

B C Cole, J R Ward, R S Jones, J F Cahill.   

Abstract

Mice injected intravenously with Mycoplasma arthritidis developed a chronic arthritis which persisted through at least 269 days. Rats similarly treated developed an acute short-term infection. The mouse disease was characterized by periods of remission and exacerbation and was proliferative in nature, gradually spreading to adjacent joints. M. arthritidis strain 158 P10 was found to be less arthritogenic for mice than for rats, but further passage of this strain in mice substantially increased its virulence. Unlike rats, mice appeared to be susceptible to a "toxin" of M. arthritidis and they developed a necrotic spreading abscess after subcutaneous administration of the organisms. Histopathological studies revealed that mice varied greatly in the degree of joint inflammation, destruction, and repair. The disease was characterized by (i) an initial acute phase with infiltration of the articular and periarticular tissues with polymorphonuclear leukocytes and a mild hyperplasia of the synovial membrane; (ii) a mixed acute-chronic phase in which new areas of acute inflammation developed alongside areas of chronic lesions; (iii) a chronic phase followed which was characterized by massive synovial proliferation with mononuclear cell infiltration, irregularity in the articulating cartilage, pannus formation, and "punched out" defects in cortical bone near cartilagenous osseous junctures. The clinical course and histopathological characteristics of the chronic phase of mouse arthritis induced by M. arthritidis closely resembled those of rheumatoid arthritis of man.

Entities:  

Mesh:

Year:  1971        PMID: 5154887      PMCID: PMC416312          DOI: 10.1128/iai.4.4.344-355.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  RECOVERY, IDENTIFICATION, AND NEUROTOXICITY OF SABIN'S TYPE A AND C MOUSE MYCOPLASMA (PPLO) FROM LYOPHILIZED CULTURES.

Authors:  J G TULLY; I RUCHMAN
Journal:  Proc Soc Exp Biol Med       Date:  1964-02

2.  The classification and nomenclature of organisms of the pleuropneumonia group.

Authors:  D G EDWARD; E A FREUNDT
Journal:  J Gen Microbiol       Date:  1956-02

3.  THE FILTRABLE MICROORGANISMS OF THE PLEUROPNEUMONIA GROUP.

Authors:  A B Sabin
Journal:  Bacteriol Rev       Date:  1941-03

4.  Effect of Animal Passage on Arthritogenic and Biological Properties of Mycoplasma arthritidis.

Authors:  L Golightly-Rowland; B C Cole; J R Ward; B B Wiley
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

5.  EXPERIMENTAL PROLIFERATIVE ARTHRITIS IN MICE PRODUCED BY FILTRABLE, PLEUROPNEUMONIA-LIKE MICROORGANISMS.

Authors:  A B Sabin
Journal:  Science       Date:  1939-03-10       Impact factor: 47.728

6.  Mycoplasmas and arthritis.

Authors:  J T Sharp
Journal:  Arthritis Rheum       Date:  1970 May-Jun

7.  Experimental arthritis in mice with Mycoplasma pulmonis.

Authors:  J A Barden; J G Tully
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

8.  Role of Biological Mimicry in the Pathogenesis of Rat Arthritis Induced by Mycoplasma arthritidis.

Authors:  J F Cahill; B C Cole; B B Wiley; J R Ward
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

9.  Immunological responses of the rat to Mycoplasma arthritidis.

Authors:  B C Cole; J F Cahill; B B Wiley; J R Ward
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

10.  Mycoplasmas as pathogens.

Authors:  L Thomas
Journal:  Yale J Biol Med       Date:  1968 Apr-Jun
View more
  46 in total

1.  Molecular characterization of Mycoplasma arthritidis membrane lipoprotein MAA1.

Authors:  L R Washburn; E J Miller; K E Weaver
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Comparison of four Mycoplasma arthritidis strains by enzyme immunoassay, metabolism inhibition, one- and two-dimensional electrophoresis, and immunoblotting.

Authors:  L R Washburn; S Hirsch
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  Antigenic mimicry of a human cellular polypeptide by Mycoplasma hyorhinis.

Authors:  P D Fernsten; K W Pekny; J R Harper; L E Walker
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  New models of chronic synovitis in rabbits induced by mycoplasmas: microbiological, histopathological, and immunological observations on rabbits injected with Mycoplasma arthritidis and Mycoplasma pulmonis.

Authors:  B C Cole; M M Griffiths; E J Eichwald; J R Ward
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.

Authors:  G Taylor; D Taylor-Robinson
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

Review 6.  Potential role of superantigen induced activation of cell mediated immune mechanisms in the pathogenesis of Crohn's disease.

Authors:  J P Ibbotson; J R Lowes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

7.  Characterization of the metabolism inhibition antigen of Mycoplasma arthritidis.

Authors:  L R Washburn; J R Ramsay; L K Roberts
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

8.  Differential induction of tumor necrosis factor alpha in murine and human leukocytes by Mycoplasma arthritidis-derived superantigen.

Authors:  L Rink; W Nicklas; L Alvarez-Ossorio; M Koester; H Kirchner
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

10.  Effect of corynebacterium parvum in the induction and course of mycoplasma arthritis of mice.

Authors:  E Kaklamani; P Kaklamanis; L Sparos; D Karalis; K Alikouli; I Koumandaki; D Trichopoulos
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.